Abstract
Haemophagocytic syndrome, diffuse alveolar haemorrhage, catastrophic antiphospholipid syndrome and various types of thrombotic microangiopathies are rare conditions with significant morbidity and mortality. A common feature is late diagnosis, which can affect the success of treatment. The aim of this review article is to summarize the basic diagnostic and therapeutic steps of the present subpopulation of critically ill patients.
Author supplied keywords
- HLH
- antiphospholipid syndrome
- caplacizumab
- catastrophic antiphospholipid syndrome
- cytokine storm syndrome
- diffuse alveolar haemorrhage
- eculizumab
- etoposide
- haemolytic-uremic syndrome
- hemophagocytic lymphohistiocytosis
- hemophagocytic syndrome
- immunosuppressive therapy
- macrophage activation syndrome
- plasma exchange
- ravulizumab
- recombinant factor VIIa
- rituximab
- thrombosis
- thrombotic microangiopathy
- thrombotic thrombocytopenic purpura
- vasculitis
Cite
CITATION STYLE
Gumulec, J., Demel, I., Lančová, K., Drbohlavová, E., Piegzová, A., Kořístek, Z., … Černý, V. (2022). Selected severe „haematological“ syndromes in adult intensive care patients. Vnitrni Lekarstvi, 68(8), 498–507. https://doi.org/10.36290/vnl.2022.107
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.